Breaking News

Takeda Licenses Trianni Discovery Platform

April 1, 2014

Adds Trianni Mouse to biologic research capabilities

Trianni, Inc. and Takeda Pharmaceutical Co. Ltd. have entered into a license agreement under which Takeda will have access to the Trianni Mouse, a monoclonal antibody discovery platform that has been optimized for the isolation of fully human therapeutics.
 
"We are very pleased to see Takeda adopt the Trianni Mouse," said Dr. Matthias Wabl, Ph.D., chairman and chief executive officer of Trianni. "With its many distinctive features, most notably a full repertoire expressed from chemically synthesized gene segments, we are confident the platform will prove highly productive for Takeda." 
 
"We are excited to add Trianni's transgenic mice to Takeda's repertoire of platform technologies for the generation of therapeutic antibodies," said Tetsuyuki Maruyama, Ph.D., general manager of Pharmaceutical Research Division of Takeda. "Takeda has a growing biologics pipeline and the Trianni Mouse is a natural addition to enhance our ongoing research capabilities in the area."
blog comments powered by Disqus
  • Setting Health-Based Exposure Limits to Support Pharmaceutical Development and Manufacturing

    Setting Health-Based Exposure Limits to Support Pharmaceutical Development and Manufacturing

    B.D. Naumann, P.J. Nigro, U. Bruen, L. Parola, D. Cragin and A. Schatz, Merck & Co., Inc. and Ashland, Inc.||May 5, 2016
    Health-based exposure limits are needed to support risk assessments

  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.